| Literature DB >> 24903211 |
Wei Wang1, Jiao Lou2, Rong Zhong3, Yan-qi Qi4, Na Shen3, Xu-zai Lu5, Yu-jia Wang6, Qing Zhang4, Li Zou3, Jia-yu Duan3, Jun-tao Ke3, Xiao-ping Miao3, Fang-qi Gong4.
Abstract
Ca(2+)/nuclear factor of activated T-cells (Ca(2+)/NFAT) signaling pathway may play a crucial role in Kawasaki disease (KD). We investigated 16 genetic variants, selected by bioinformatics analyses or previous studies, in 7 key genes involved in this pathway in a Chinese population. We observed a significantly or marginally increased KD risk associated with rs2720378 GC + CC genotypes (OR = 1.39, 95% CI = 1.07-1.80, P = 0.014) or rs2069762 AC + CC genotypes (OR = 1.28, 95% CI = 0.98-1.67, P = 0.066), compared with their wild type counterparts. In classification and regression tree analysis, individuals carrying the combined genotypes of rs2720378 GC or CC genotype, rs2069762 CA or CC genotype and rs1561876 AA genotype exhibited the highest KD risk (OR = 2.12, 95% CI = 1.46-3.07, P < 0.001), compared with the lowest risk carriers of rs2720378 GG genotype. Moreover, a significant dose effect was observed among these three variants (Ptrend < 0.001). In conclusion, this study implicates that single- and multiple-risk genetic variants in this pathway might contribute to KD susceptibility. Further studies on more comprehensive single nucleotide polymorphisms, different ethnicities and larger sample sizes are warranted, and the exact biological mechanisms need to be further clarified.Entities:
Mesh:
Substances:
Year: 2014 PMID: 24903211 PMCID: PMC4047536 DOI: 10.1038/srep05208
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Association between individual SNP and KD risk
| W/H/V frequency | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chr | Gene | rs ID | MAF in CHB | KD cases | Controls | Reference/Variant allele | OR | 95% CI | LR |
| 4 | |||||||||
| CASP3 | rs2720378 | 0.326 | 184/186/56 | 253/191/49 | G/C | ||||
| IL-2 | rs2069762 | 0.239 | 170/193/55 | 230/210/52 | A/C | 1.28 | 0.98–1.67 | 0.066 | |
| STIM2 | rs10263 | 0.367 | 174/196/53 | 207/220/65 | A/G | 0.94 | 0.64–1.39 | 0.760 | |
| 11 | |||||||||
| STIM1 | rs1561876 | 0.344 | 244/151/23 | 266/193/32 | A/G | 0.84 | 0.65–1.10 | 0.204 | |
| STIM1 | rs3750994 | 0.244 | 298/112/16 | 334/137/20 | T/G | 0.91 | 0.69–1.21 | 0.529 | |
| STIM1 | rs3750996 | 0.133 | 249/142/19 | 287/172/25 | A/G | 0.94 | 0.72–1.23 | 0.663 | |
| 18 | |||||||||
| NFATc1 | rs9966033 | 0.378 | 158/209/53 | 184/222/74 | T/C | 0.79 | 0.54–1.16 | 0.230 | |
| NFATc1 | rs754093 | 0.311 | 176/197/45 | 222/206/63 | T/G | 0.82 | 0.55–1.23 | 0.338 | |
| NFATc1 | rs7227107 | 0.367 | 167/201/54 | 194/224/68 | A/G | 0.90 | 0.62–1.33 | 0.600 | |
| 19 | |||||||||
| ITPKC | rs28493229 | 0.070 | 359/63/4 | 422/71/0 | G/C | 1.11 | 0.77–1.59 | 0.573 | |
| ITPKC | rs10420685 | 0.178 | 230/158/38 | 267/184/40 | A/G | 1.10 | 0.69–1.76 | 0.675 | |
| ITPKC | rs2290692 | 0.433 | 109/190/112 | 111/238/119 | G/C | 0.86 | 0.64–1.17 | 0.344 | |
| ITPKC | rs2561530 | 0.270 | 230/160/33 | 258/202/28 | A/G | 1.39 | 0.83–2.34 | 0.215 | |
| ITPKC | rs4802085 | 0.500 | 129/187/103 | 129/238/102 | G/C | 1.17 | 0.86–1.60 | 0.317 | |
| 20 | |||||||||
| NFATc2 | rs6013193 | 0.330 | 150/210/67 | 157/251/84 | T/G | 0.87 | 0.66–1.14 | 0.302 | |
Abbreviations: MAF, minor allele frequency; CHB, Han Chinese in Beijing; Chr, chromosome; W, wild type homozygote; H, heterozygote; V, variant homozygote; OR, odds ratio; 95%CI, 95% confidence interval; LR, logistic regression
*MAF was downloaded from the online database of HapMap for Han Chinese in Beijing, China
†OR calculation was conducted under assumption that variant alleles were risk alleles
‡All the P values were adjusted for gender. The positive results were in bold
§The inheritance model of the risk alleles was dominant
¶The inheritance model of the risk alleles was recessive
∥MAF was downloaded from the online database of 1000 Genomes for Han Chinese in Beijing, China
Figure 1CART analysis of genetic variants in Ca2+/NFAT signaling pathway and KD risk.
Cases and controls are denoted by white and black box respectively, and each node contains frequencies and percentages of cases and controls in each subgroup.
Risk estimates of CART terminal nodes
| Node | Genotype | KD cases | Controls | Case rate | OR | 95% CI | LR |
|---|---|---|---|---|---|---|---|
| 1 | rs2720378 (W) | 185 (43.22) | 253 (51.32) | 42.2 | Ref. | Ref. | |
| 3 | rs2720378 (HV)-rs2069762 (W) | 91 (21.26) | 117 (23.73) | 43.8 | 1.06 | 0.76–1.48 | 0.718 |
| 5 | rs2720378 (HV)-rs2069762 (HV)-rs1561876 (HV) | 56 (13.08) | 61 (12.37) | 47.9 | 1.26 | 0.83–1.89 | 0.276 |
| 6 | rs2720378 (HV)-rs2069762 (HV)-rs1561876 (W) | 96 (22.43) | 62 (12.58) | 60.8 |
Abbreviations: CART, classification and regression tree; KD, Kawasaki disease; OR, odds ratio; 95%CI, 95% confidence interval; LR, logistic regression; W, wild type homozygote; H, heterozygote; V, variant homozygote
*Case rate is the percentage of KD patients among all individuals in each node
†ORs of terminal nodes were calculated by LR analysis adjusted for gender
‡All the P values were adjusted for gender. The positive results were in bold
Cumulative effect of the 3 SNPs (rs2720378 rs2069762 rs1561876) between KD patients and normal controls
| Number of risk alleles | KD cases (%) | Controls (%) | OR | 95% CI | LR |
|---|---|---|---|---|---|
| 0–2 | 144 (35.38) | 216 (44.08) | Ref. | Ref. | |
| 3–4 | 222 (54.55) | 253 (51.63) | |||
| 5–6 | 41 (10.07) | 21 (4.29) | |||
| Cochran-Armitage Trend Test | |||||
Abbreviations: KD, Kawasaki disease; OR, odds ratio; 95%CI, 95% confidence interval; LR, logistic regression
*All the P values were adjusted for gender. The positive results were in bold